Translations:Dipeptidyl peptidase-4 inhibitor/5/en
Jump to navigation
Jump to search
A 2018 meta-analysis found no favorable effect of DPP-4 inhibitors on all-cause mortality, cardiovascular mortality, myocardial infarction or stroke in patients with type 2 diabetes.